Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Marc Lalande, Tony Gordon

Premium

Marc Lalande has been appointed to the new position of executive director of Genomics and Personalized Medicine Programs at the University of Connecticut where he will help lead the development of research and training programs for the Institute of Systems Genomics, collaborations with The Jackson Laboratory for Genomic Medicine, and industry and government partnerships for the planned CT Institute for Medical Innovation and Applied Health Care Economics.

Lalande will also maintain his current positions as the Health Net professor and chairman of the Department of Genetics and Developmental Biology and director of both the University of Connecticut Stem Cell Institute and the Institute for Systems Genomics. He will step down from his position as senior associate dean for research planning and coordination at the UConn School of Medicine.


Genesis Genetics has appointed Tony Gordon to lab director of the company's UK operations and vice president of its US operations. Gordon will sign off all patient reports in the UK and lead the company's efforts to expand testing operations throughout the UK.

Gordon joins Genesis Genetics from BlueGnome. He holds a PhD from Nottingham University.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.